CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

HP:0012047: HemeralopiaHPO

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug769 Non invasive visual acuity testing Wiki 1.00

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D014786 Vision Disorders NIH 1.00
D015354 Vision, Low NIH 1.00
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0000505 Visual impairment HPO 1.00

There is one clinical trial.

Clinical Trials

1 Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic

Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use of telemedicine to continue ophthalmic care while maintaining patient and provider social distancing. As part of remote examinations, patients may be expected to perform home eye testing for visual acuity and the use of various home visual acuity charts have been proposed to provide clinicians with this vital data. However, the use of home visual acuity exams has not been validated in our patient population. This project aims to determine the efficacy and validity of measuring visual acuity at home with a printed-out ETDRS chart.

NCT04391166 Visual Impairment Other: Non invasive visual acuity testing
MeSH:Coronavirus Infections Vision Disorders Vision, Low
HPO:Hemeralopia Metamorphopsia Visual impairment

Primary Outcomes

Description: Best Visual Acuity per eye

Measure: Best Corrected Visual Acuity (BCVA) Per Eye

Time: From the time they sign the consent until we take their BCVA in clinic. Approximately 1-2 weeks.

HPO Nodes